Atlas Trials

Study of Efficacy and Safety of LIB003 in Patient With CVD on Statins Requiring Additional LDL-C Reduction

Clinical trial NCT04797247 · UNKNOWN

Trial details

NCT number
NCT04797247
Sponsor
LIB Therapeutics LLC
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Cardiovascular DiseasesHyper-LDL-cholesterolemia
Start date
2021-04-22
Primary completion
2023-11-15
Enrollment
900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.